IDEXX Laboratories, Inc. (IDXX) News
Track canonical SquawkNews coverage tagged to IDXX, IDEXX Laboratories, Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
IDEXX to Acquire CoVetAI for Veterinary AI Workflow Software
IDEXX Laboratories will acquire CoVetAI Inc., which provides AI-native ambient listening and clinical workflow software for veterinary practices. Financial terms were not disclosed.
EQUITY | Sep 16, 2026, 12:09 PM UTC
M
IDEXX Laboratories acquires CoVetAI
IDEXX Laboratories acquired CoVetAI to advance veterinary workflow intelligence.
EQUITY | Sep 16, 2026, 11:00 AM UTC
L
IDEXX director Kingsley Lawrence D sells $1,172,177 of common stock
Kingsley Lawrence D, an IDEXX Laboratories director, sold common stock on September 4, 2026. The shares were sold at a weighted average price of $532.0826 each for a reported total of $1,172,177.
EQUITY | Sep 09, 2026, 09:11 PM UTC
L
IDEXX Laboratories to participate in Morgan Stanley healthcare conference
IDEXX Laboratories announced participation in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Aug 31, 2026, 06:00 PM UTC
H
Why Is IDEXX Laboratories Stock Gaining Tuesday?
IDEXX Laboratories, Inc. (NASDAQ: IDXX ) stock rose Tuesday after the veterinary diagnostics company reported second-quarter results that topped Wall Street estimates and raised its full-year earnings outlook. Companion
EARNINGS | Aug 04, 2026, 03:39 PM UTC
H
IDEXX Laboratories Q2 2026 Earnings Call Transcript
IDEXX Laboratories (NASDAQ: IDXX ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For
EARNINGS | Aug 04, 2026, 01:35 PM UTC
H
IDEXX Reports Q2 Gross Margin 64%
IDEXX Q2 revenue beats estimates
EARNINGS | Aug 04, 2026, 10:44 AM UTC
H
IDXX - IDEXX Laboratories Announces Second Quarter Results
IDXX - IDEXX Laboratories Announces Second Quarter Results
EARNINGS | Aug 04, 2026, 10:40 AM UTC
H
IDEXX Laboratories Raises FY2026 GAAP EPS Guidance from $14.45-$14.90 to $14.69-$14.94 vs $14.67 Est; Narrows FY2026 Sales Guidance from $4.
IDEXX Laboratories (NASDAQ: IDXX ) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94 vs $14.67 analyst estimate. Narrows FY2026 sales outlook from $4.675 billion-$4.760 billion to $4.700 billion-$4.745
EARNINGS | Aug 04, 2026, 10:31 AM UTC
H
US Stocks: Implied EPS Movers
Multiple US stocks have implied EPS movers
EARNINGS | Aug 03, 2026, 06:15 PM UTC
L
BAH CNI FIX GSHD MRSH PSX RJF RNR SXT THC WRB AAL CHTR HAL HCA IDXX MCD MSFT MTDR ZTS PT changes @ UBS
BAH CNI FIX GSHD MRSH PSX RJF RNR SXT THC WRB AAL CHTR HAL HCA IDXX MCD MSFT MTDR ZTS PT changes @ UBS
EQUITY | Jul 27, 2026, 12:50 PM UTC
L
IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention
IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention
EQUITY | Jul 27, 2026, 12:09 PM UTC